Tango Therapeutics (TNGX) EBT (2020 - 2026)
Tango Therapeutics (TNGX) posted quarterly EBT of -$45.5 million for Q1 2026, down 14.23% year-over-year from -$53.1 million in Q1 2025, and down 17.29% quarter-over-quarter from -$38.8 million in Q4 2025.
Tango Therapeutics (TNGX) EBT (2020 - 2026) Analysis & Trends
Tango Therapeutics' EBT history runs 7 years deep, the most recent figure standing at -$45.5 million for Q1 2026.
- In Q1 2026, EBT fell 14.23% year-over-year to -$45.5 million; the TTM figure through Mar 2026 stood at -$107.3 million (up 18.78% YoY), while the FY2025 annual figure was -$101.6 million, up 21.91% from the prior year.
- EBT for Q1 2026 stood at -$45.5 million, down from -$38.8 million in the prior quarter.
- The five-year high for EBT was $15.9 million in Q3 2025, with the low at -$45.5 million in Q1 2026.
- The 5-year median for EBT is -$29.0 million (2022), against an average of -$28.6 million.
- The sharpest annual moves came in 2022 and 2025: EBT slumped 450.62% in 2022, then jumped 154.53% in 2025.
- Tango Therapeutics' EBT stood at -$29.0 million in 2022, then fell by 5.88% to -$30.7 million in 2023, then dropped by 22.48% to -$37.6 million in 2024, then declined by 3.14% to -$38.8 million in 2025, then dropped by 17.29% to -$45.5 million in 2026.
- Business Quant data shows TNGX's EBT at -$45.5 million in Q1 2026, -$38.8 million in Q4 2025, and $15.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 541.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -644.37 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 312.46 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,828.29 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 81.49 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 177.81 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -11.37 Mn |
| 10 | Tango Therapeutics | 4.32 Bn | 3.30 Bn | - | -55.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -55.34 Mn |
| Mar 31, 2026 | -45.51 Mn |
| Dec 31, 2025 | -38.80 Mn |
| Sep 30, 2025 | 15.87 Mn |
| Jun 30, 2025 | -38.82 Mn |
| Mar 31, 2025 | -39.84 Mn |
| Dec 31, 2024 | -37.62 Mn |
| Sep 30, 2024 | -29.11 Mn |
| Jun 30, 2024 | -25.49 Mn |
| Mar 31, 2024 | -37.87 Mn |
| Dec 31, 2023 | -30.72 Mn |
| Sep 30, 2023 | -22.24 Mn |
| Jun 30, 2023 | -20.65 Mn |
| Mar 31, 2023 | -28.01 Mn |
| Dec 31, 2022 | -29.01 Mn |
| Sep 30, 2022 | -29.05 Mn |
| Jun 30, 2022 | -24.86 Mn |
| Mar 31, 2022 | -25.21 Mn |
| Dec 31, 2021 | -21.87 Mn |
| Sep 30, 2021 | -19.53 Mn |